Executive Summary

The medical technology (medtech) sector stands at the confluence of several structural forces: global pricing reforms, a shift toward outpatient care, supply chain volatility, the adoption of GLP-1 therapies, and the rise of platform-based enabling technologies. While these trends are often discussed in the context of industry competitiveness, they carry profound implications for urban development. Cities are not merely passive hosts to healthcare delivery; they are active participants in shaping health outcomes, infrastructure investment, and economic resilience. This article analyzes five medtech trends identified in Clarivate's Medtech Trends to Watch 2026 report through a metropolitan lens, illustrating how each trend influences urban planning, public health, and city competitiveness. Understanding these dynamics is essential for policymakers, urban planners, and business leaders seeking to build future-ready cities.

Introduction

Healthcare has always been a cornerstone of urban life. From the earliest hospitals to modern medical districts, cities have concentrated medical expertise, technology, and care. In the 21st century, the relationship between health and urbanism has deepened, with growing recognition that the built environment—housing, transport, green spaces—directly influences health outcomes. Simultaneously, medical technology is transforming how care is delivered, where it is delivered, and who can access it. As cities strive to become smarter, more sustainable, and more competitive, they must integrate these changes into long-term metropolitan strategies.

The five medtech trends outlined by Clarivate—China's volume-based procurement expansion, the migration to ambulatory surgical centers, supply chain reshoring, the GLP-1 effect, and platform-based competition—represent more than industry shifts. They signal changes in healthcare demand, location patterns, and infrastructure needs that cities must anticipate. This article provides an evidence-based assessment of these trends and their urban implications, drawing on the analytical framework of Clarivate's proprietary data and expert insights.

Urban Context

Cities account for a disproportionate share of healthcare spending and medical innovation. In the United States, metropolitan regions host major academic medical centers, biotech clusters, and healthtech startups. Similar patterns exist globally, from Shenzhen's device manufacturing ecosystem to London's life sciences corridor. Medtech companies often anchor urban economies, attracting talent and investment. However, the industry's structural transformation is altering this landscape. Pricing pressures in major markets force companies to rethink portfolios, while care delivery shifts affect where hospitals are built and how they operate. For cities, this means adapting land-use policies, transportation networks, and public health strategies to accommodate new models of care and innovation.

Main Analysis

1. Volume-Based Procurement in Mainland China: Global Pricing Pressures and Urban Market Dynamics

Mainland China's latest national volume-based procurement (VBP) round has redefined the economics of medtech. Originally a mechanism to improve access and control costs, VBP has evolved into a market-structuring tool that applies sophisticated anchor-price logic, deep price compression, and allocation systems favoring domestic manufacturers. For global medtech companies, this is no longer a localized policy; it sets benchmarks that influence negotiations in other markets.

Urban implications: Chinese cities, particularly manufacturing hubs like Shenzhen and Suzhou, are direct beneficiaries of VBP's support for domestic innovation. Government policies encourage the development of local champions, boosting urban economic ecosystems. At the same time, multinational companies face margin erosion, prompting them to rationalize product portfolios and investment decisions. Cities that rely on medtech manufacturing may see shifts in job creation and industrial composition. For urban policymakers, understanding VBP's reach is essential for economic development strategies, workforce training, and trade relationships.

2. The Rise of Ambulatory Surgical Centers: Decentralizing Care and Reshaping Urban Land Use

Medicare's 2026 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System Final Rule expands the ASC Covered Procedure List and phases out the inpatient-only list. This accelerates a decade-long trend of procedures moving from hospitals to outpatient settings, including cardiac ablation and other higher-acuity interventions. The shift builds on patterns in orthopedics and general surgery where ASCs have become integral to growth.

Urban implications: This decentralization has spatial consequences. Hospitals are no longer the sole anchors of urban health districts. ASCs can locate in suburban or mixed-use neighborhoods, closer to patient populations, reducing travel burdens and improving access. For urban planners, this means zoning codes must accommodate new facility types, and transportation systems must be configured to serve dispersed healthcare destinations. Real estate markets may experience increased demand for flexible medical spaces, while underutilized hospital facilities require adaptive reuse. The expansion of ASCs also creates opportunities for urban regeneration, particularly in areas lacking adequate healthcare access.

3. Supply Chain Pressures and Manufacturing Reshoring: A Test for Urban Industrial Resilience

Global trade tensions, tariff exposure, and material cost volatility have made supply chain resilience a strategic priority. Medtech companies are diversifying sourcing, re-evaluating manufacturing footprints, and investing in flexible multi-region production. Larger manufacturers are using scale and technology to buffer against volatility, potentially consolidating market power.

Urban implications: Manufacturing geography is central to urban economies. Cities with medtech factories face both risks and opportunities. Reshoring and 'friend-shoring' could attract investment to cities in North America and Europe, but competition is intense. Urban leaders must invest in advanced manufacturing skills, industrial parks, and logistics infrastructure to capture this opportunity. Supply chain resilience also intersects with climate adaptation; cities vulnerable to ports congestion or extreme weather must integrate healthcare supply dependencies into resilience planning. The decentralization of production could weaken agglomeration economies in traditional clusters, encouraging polycentric urban development.

4. The GLP-1 Effect: Public Health Transformation and Urban Health Economics

Glucagon-like peptide-1 (GLP-1) receptor agonists, originally designed for diabetes, have become blockbuster therapies for weight management. Their adoption alters patient behavior, referral patterns, and demand for adjacent medical technologies. While bariatric surgery remains more effective for substantial weight loss, GLP-1s have shifted clinical pathways and affected procedure volumes, from obesity surgery to cardiovascular monitoring.

Urban implications: Cities are on the frontlines of the obesity epidemic. Widespread GLP-1 use could reduce the prevalence of obesity-related chronic diseases, potentially lowering urban healthcare costs and improving productivity. However, the effect is uneven. Decentralized clinics prescribing these drugs may reduce demand for certain hospital services while increasing demand for digital health apps and remote monitoring. City health departments must assess how these therapies influence public health campaigns, food environments, and preventive care. The economic ripple effects will be significant, from pharmacy demand to urban insurance markets. Moreover, the long-term safety and equitable access remain critical policy questions.

5. Enabling Technologies and Platform-Based Competition: The Digital Backbone of Smart Health Cities

Medtech has moved beyond standalone devices to integrated platforms combining robotics, imaging, navigation, and digital workflow software. These enabling technologies are becoming central to clinical planning, surgical execution, and postoperative care, with companies investing heavily in ecosystem architectures that anchor service lines and unlock data-driven value. Open-platform systems are expanding flexibility and creating new competitive dynamics.

Urban implications: This is the essence of the smart health city. Platform technologies rely on digital infrastructure—high-bandwidth networks, edge computing, cybersecurity—and data interoperability. Cities that deploy robust digital infrastructure become more attractive for medtech innovation and clinical adoption. Urban AI and digital twins can simulate surgical workflows, optimize hospital operations, and even guide public health responses. The concentration of these capabilities creates innovation districts where research, startups, and clinical care coexist. However, cities must address privacy, equity, and governance to ensure that platform-based health does not widen disparities.

Metropolitan Impact

These medtech trends will significantly influence urban economies, infrastructure, and quality of life over the coming decade.

• Urban Economies: Hospitals and medtech firms are major employers and tax base contributors. The transition to outpatient care and platform-based competition will shift job types, demanding new skills in data science, robotics, and logistics. Cities that invest in workforce development can attract high-value medtech investments.
• Infrastructure: Healthcare facility planning must align with transportation networks. Decentralized ASCs require accessible locations, affecting road, transit, and parking design. Digital infrastructure is now as critical as physical infrastructure, requiring fiber deployment and 5G coverage to support telemedicine and AI platforms.
• Housing and Real Estate: The rise of outpatient facilities and shrinking hospital footprints may free land for mixed-use development. Adaptive reuse of older hospitals offers opportunities for housing, especially in cities facing affordability pressures. Conversely, medtech manufacturing clusters generate industrial real estate demand.
• Public Services: Health departments must adapt to new care models, monitoring population health, and ensuring equitable access to therapies like GLP-1s. Procurement policies, informed by global pricing trends, can manage public health budgets.
• Resilience: Supply chain shocks have highlighted the need for urban governments to diversify medical supply sources and strengthen local emergency preparedness. Climate resilience is intertwined with healthcare infrastructure, particularly after extreme weather events.
• Competitiveness: Cities that integrate health technology into innovation strategies will gain a competitive edge, attracting talent and investment from global medical device and digital health industries.

Strategic Insights

For city leaders and urban stakeholders, the following strategic insights emerge:

• Plan for Care Decentralization: Update zoning and land-use policies to permit and encourage ambulatory care centers in mixed-use neighborhoods. Ensure that transit investments connect residents to these facilities, reducing health access disparities.
• Invest in Digital Health Infrastructure: Treat digital infrastructure as a public utility, expanding broadband and edge computing to support telemedicine, remote monitoring, and AI-based diagnostics. Promote interoperability standards to enable data sharing across city agencies and health systems.
• Foster Innovation Districts: Develop mixed-urban areas that bring together research institutions, medtech startups, and clinical care, leveraging anchor institutions to stimulate economic development. Use public-private partnerships to fund shared labs, incubators, and data platforms.
• Strengthen Supply Chain Resilience: Collaborate with industries and logistics operators to diversify medical supply sources and create local emergency stockpiles. Enhance urban manufacturing capacity and advanced skills training to capture reshoring opportunities.
• Address Equity in Health Technology: As GLP-1 therapies and platform technologies advance, ensure that all city residents can benefit. Design public health campaigns and reimbursement models that reduce barriers, and monitor artificial intelligence algorithms for bias.
• Integrate Health into Urban Planning: Elevate public health as a core consideration in urban planning, using health impact assessments for major infrastructure and land-use decisions. Connect climate adaptation to healthcare, as hospitals and supply chains are vulnerable to heat waves and floods.

Future Outlook

Looking 5–15 years ahead, medtech trends will converge with broader urban transformations.

• Smart Health Cities: Cities will deploy urban digital twins that simulate health service demand, traffic to clinics, and environmental impacts. AI-driven predictive analytics will guide public health interventions and infrastructure investment.
• Urban Mobility and Health Access: The shift to micro-delivery and mobility-as-a-service will improve access to care for underserved populations. Autonomous vehicles could ferry patients to ASCs, while drones may deliver medical supplies in emergency situations.
• Climate and Health: Climate adaptation will be integral to health infrastructure, with hospitals designed to operate during blackouts, and cold chains for pharmaceuticals powered by renewable microgrids. Urban greening will be recognized as a public health intervention.
• Reshaped Economies: Medtech clusters will evolve into digital health ecosystems, with technology platforms and data analytics playing a larger role than hardware production. Cities that nurture AI and robotics talent will lead in surgical innovation and remote care.
• Housing and Health: Mixed-use development and 15-minute city concepts will prioritize healthy living, embedding preventive care in neighborhoods. Real estate developers will partner with health systems to deliver wellness-focused communities.
• Urban Governance: New models of public-private partnership will emerge for health infrastructure, with cities co-investing in platforms, data governance, and outcome-based financing. Regional cooperation across municipalities will manage commute-sheds and healthcare catchment areas holistically.

Conclusion

Medtech trends are not isolated industry phenomena; they are forces that reshape cities. From the decentralization of surgical care to the rise of platform-enabled health ecosystems, these developments will require thoughtful adaptation in urban planning, infrastructure investment, and public policy. Cities that proactively integrate medtech innovation into metropolitan strategies will enhance their competitiveness, resilience, and quality of life. As Clarivate's insights reveal, the medtech landscape is accelerating into a new age—and so must our cities.